Published in Clin Exp Immunol on November 01, 1985
A surrogate hepatitis B virus antigenic epitope represented by a synthetic peptide and an internal image antiidiotype antibody. J Exp Med (1986) 0.81
Genetic restriction of cytolysis during equid herpesvirus 1 subtype 2 infection. Clin Exp Immunol (1987) 0.77
Continuous cultures of fused cells secreting antibody of predefined specificity. Nature (1975) 83.56
Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution. Nature (1981) 24.17
Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature (1981) 19.90
A human T cell-specific cDNA clone encodes a protein having extensive homology to immunoglobulin chains. Nature (1984) 10.02
The role of cell-mediated immunity in bacterial infections. Rev Infect Dis (1982) 9.26
Isolation of cDNA clones encoding T cell-specific membrane-associated proteins. Nature (1984) 8.89
Requirement of thymus (T) lymphocytes for resistance to listeriosis. J Exp Med (1972) 8.25
Vaccinia virus: a selectable eukaryotic cloning and expression vector. Proc Natl Acad Sci U S A (1982) 7.81
Individual Antigenic Specificity of Isolated Antibodies. Science (1963) 7.27
New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development. Microbiol Rev (1983) 7.16
Construction of poxviruses as cloning vectors: insertion of the thymidine kinase gene from herpes simplex virus into the DNA of infectious vaccinia virus. Proc Natl Acad Sci U S A (1982) 7.04
Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus. Nature (1978) 6.59
Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives. Biochem Biophys Res Commun (1974) 6.53
Delayed hypersensitivity and arthus reactivity in relation to host resistance in salmonella-infected mice. J Immunol (1968) 5.71
Immunological phenomena in leprosy and related diseases. Adv Immunol (1971) 5.55
Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence. Nature (1982) 5.50
Cistrons encoding Escherichia coli heat-labile toxin. J Bacteriol (1979) 5.43
Infectious vaccinia virus recombinants that express hepatitis B virus surface antigen. Nature (1983) 5.25
Immunological relationships among the myeloma proteins. J Exp Med (1955) 5.11
Expression and function of idiotypes of lymphocytes. Adv Immunol (1978) 4.16
The relationship of delayed hypersensitivity to acquired cellular resistance. Br Med Bull (1967) 4.03
Excretion of hepatitis B surface antigen particles from mouse cells transformed with cloned viral DNA. Proc Natl Acad Sci U S A (1980) 3.97
Synthesis and assembly of hepatitis B virus surface antigen particles in yeast. Nature (1982) 3.82
Construction of live vaccines using genetically engineered poxviruses: biological activity of vaccinia virus recombinants expressing the hepatitis B virus surface antigen and the herpes simplex virus glycoprotein D. Proc Natl Acad Sci U S A (1984) 3.58
Expression of the hepatitis B virus surface antigen gene in cell culture by using a simian virus 40 vector. Proc Natl Acad Sci U S A (1981) 3.38
Priming for and induction of anti-poliovirus neutralizing antibodies by synthetic peptides. Nature (1983) 3.35
Antibodies against a preselected peptide recognize and neutralize foot and mouth disease virus. EMBO J (1982) 3.32
Expression in Escherichia coli of hepatitis B virus DNA sequences cloned in plasmid pBR322. Nature (1979) 3.03
Human T-cell clones recognize chemically synthesized peptides of influenza haemagglutinin. Nature (1982) 2.84
A BRADYKININ-POTENTIATING FACTOR (BPF) PRESENT IN THE VENOM OF BOTHROPS JARARCA. Br J Pharmacol Chemother (1965) 2.73
[A new allotype form of rabbit serum gamma-globulins, apparently associated with antibody function and specificity]. C R Hebd Seances Acad Sci (1963) 2.64
Lymphocyte suppression in leprosy induced by unique M. leprae glycolipid. Nature (1984) 2.63
Distinctive adjuvanticity of synthetic analogs of mycobacterial water-soluble components. Cell Immunol (1976) 2.61
Cross-protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivity. Eur J Immunol (1984) 2.57
Protective monoclonal antibodies recognising stage-specific merozoite antigens of a rodent malaria parasite. Nature (1980) 2.55
Immunological aspects of leprosy--present status. Prog Allergy (1978) 2.37
Construction of a potential bivalent vaccine strain: introduction of Shigella sonnei form I antigen genes into the galE Salmonella typhi Ty21a typhoid vaccine strain. Infect Immun (1981) 2.15
Immunochemical study of antigenic specificity in delayed hypersensitivity. V. Immunization with monovalent low molecular weight conjugates. J Exp Med (1966) 2.06
Implications of the presence of an internal image of the antigen in anti-idiotypic antibodies: possible application to vaccine production. Clin Immunol Immunopathol (1981) 2.05
Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses. Nature (1984) 1.90
Prophylactic immunization against experimental leishmaniasis: I. Protection induced in mice genetically vulnerable to fatal Leishmania tropica infection. J Immunol (1982) 1.89
Antibodies that react with predetermined sites on proteins. Science (1983) 1.87
Anti-influenza response achieved by immunization with a synthetic conjugate. Proc Natl Acad Sci U S A (1982) 1.85
Protective immunization of mice with specific HSV-1 glycoproteins. Immunology (1983) 1.77
Biological activity of a new synthetic muramyl peptide adjuvant devoid of pyrogenicity. Infect Immun (1982) 1.73
Neonatal administration of idiotype or antiidiotype primes for protection against Escherichia coli K13 infection in mice. J Exp Med (1984) 1.73
Induction of influenza A virus cross-reactive cytotoxic T cells by a nucleoprotein/haemagglutinin preparation. J Gen Virol (1985) 1.70
Antibodies reactive with native lysozyme elicited by a completely synthetic antigen. Proc Natl Acad Sci U S A (1971) 1.67
Immunity in experimental salmonellosis. II. Basis for the avirulence and protective capacity of gal E mutants of Salmonella typhimurium. Infect Immun (1971) 1.62
Protective immunity to Nippostrongylus brasiliensis: the sequence of events which expels worms from the rat intestine. Immunology (1971) 1.51
The smallpox story: life and death of an old disease. Microbiol Rev (1983) 1.44
Prophylactic immunization against experimental leishmaniasis. II. Further characterization of the protective immunity against fatal Leishmania tropica infection induced by irradiated promastigotes. J Immunol (1984) 1.39
Preparation and properties of an artificial antigen immunologically related to tobacco mosaic virus. Biochim Biophys Acta (1963) 1.37
Successful immunization with a totally synthetic diphtheria vaccine. Proc Natl Acad Sci U S A (1982) 1.26
Genetically restricted cell-mediated cytotoxicity in cattle immune to Theileria parva. Nature (1981) 1.21
Immunological properties of monoclonal antibodies specific for meningococcal polysaccharides: the protective capacity of IgM antibodies specific for polysaccharide group B. J Gen Microbiol (1983) 1.14
Cells mediating delayed-type hypersensitivity in the lungs of mice infected with an influenza A virus. Scand J Immunol (1980) 1.07
Vaccination against cutaneous leishmaniasis in mice using nonpathogenic cloned promastigotes of Leishmania major and importance of route of injection. Aust J Exp Biol Med Sci (1984) 1.02
Immunodominant protein epitopes. I. Induction of suppression to hen egg white lysozyme is obliterated by removal of the first three N-terminal amino acids. Eur J Immunol (1984) 1.02
Inhibition of pathogenic effect of effector T cells by specific suppressor T cells during influenza virus infection in mice. Nature (1983) 0.98
Induction of anti-tobacco mosaic virus antibodies in mice by rabbit antiidiotypic antibodies. J Exp Med (1984) 0.98
Sendai virus-specific T-cell clones: induction of cytolytic T cells by an anti-idiotypic antibody directed against a helper T-cell clone. Proc Natl Acad Sci U S A (1984) 0.96
Structural requirements for opioid activity of analogues of the enkephalins. Proc R Soc Lond B Biol Sci (1977) 0.90
Genetic engineering and pharmaceuticals. Nature (1984) 0.86
Studies on humoral immunity against Taenia taeniaeformis infection in rats. J Helminthol (1978) 0.79
End of road for barnwell. Science (1983) 0.76
Synthetic viral vaccines. Annu Rev Microbiol (1984) 0.76
The impact of new technologies on vaccine development. Biotechnol Genet Eng Rev (1984) 0.76
Malaria: blood-stage antigens cloned. Nature (1984) 0.75
Altered immune responses in mice lacking inducible nitric oxide synthase. Nature (1995) 6.20
Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-alpha production in rheumatoid arthritis. Nat Med (1997) 4.03
Selective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells. J Exp Med (1998) 3.53
Characterization of aromatic- and purine-dependent Salmonella typhimurium: attention, persistence, and ability to induce protective immunity in BALB/c mice. Infect Immun (1988) 3.44
The role of interleukin-15 in T-cell migration and activation in rheumatoid arthritis. Nat Med (1996) 2.99
Immunological regulation of experimental cutaneous leishmaniasis. III. Nature and significance of specific suppression of cell-mediated immunity in mice highly susceptible to Leishmania tropica. J Exp Med (1980) 2.97
A proinflammatory role for IL-18 in rheumatoid arthritis. J Clin Invest (1999) 2.65
Cross-protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivity. Eur J Immunol (1984) 2.57
Selective expression and functions of interleukin 18 receptor on T helper (Th) type 1 but not Th2 cells. J Exp Med (1998) 2.40
The role of TH1 and TH2 cells in a rodent malaria infection. Science (1993) 2.38
Immunologic regulation of experimental cutaneous leishmaniasis. V. Characterization of effector and specific suppressor T cells. J Immunol (1982) 2.21
Interleukin-10 (IL-10) inhibits the induction of nitric oxide synthase by interferon-gamma in murine macrophages. Biochem Biophys Res Commun (1992) 2.08
Nitric oxide and asthmatic inflammation. Immunol Today (1995) 2.01
Functional heterogeneity of CD4+ T cells in leishmaniasis. Immunol Today (1989) 1.97
Regulation of delayed-type hypersensitivity. I. T suppressor cells for delayed-type hypersensitivity to sheep erythrocytes in mice. Eur J Immunol (1977) 1.94
Salmonella typhimurium aroA mutants as carriers of the Escherichia coli heat-labile enterotoxin B subunit to the murine secretory and systemic immune systems. Microb Pathog (1987) 1.93
Immune response to chemically modified flagellin. 3. Enhanced cell-mediated immunity during high and low zone antibody tolerance to flagellin. J Exp Med (1972) 1.90
Oral Salmonella typhimurium (AroA-) vaccine expressing a major leishmanial surface protein (gp63) preferentially induces T helper 1 cells and protective immunity against leishmaniasis. J Immunol (1990) 1.90
Regulation of delayed-type hypersensitivity. III. Effect of cyclophosphamide on the suppressor cells for delayed-type hypersensitivity to sheep erythrocytes in mice. Eur J Immunol (1978) 1.89
Regulation of the immune response by nitric oxide differentially produced by T helper type 1 and T helper type 2 cells. Eur J Immunol (1994) 1.89
Prophylactic immunization against experimental leishmaniasis: I. Protection induced in mice genetically vulnerable to fatal Leishmania tropica infection. J Immunol (1982) 1.89
Production of nitric oxide in the synovial membrane of rheumatoid and osteoarthritis patients. J Exp Med (1996) 1.85
Regulation of tumor necrosis factor production by adrenaline and beta-adrenergic agonists. J Immunol (1992) 1.83
T cells primed by influenza virion internal components can cooperate in the antibody response to haemagglutinin. Nature (1979) 1.82
Production of nitric oxide and superoxide by activated macrophages and killing of Leishmania major. Eur J Immunol (1994) 1.82
Soluble IL-15 receptor alpha-chain administration prevents murine collagen-induced arthritis: a role for IL-15 in development of antigen-induced immunopathology. J Immunol (1998) 1.81
Th1 and Th2 CD4+ T cells provide help for B cell clonal expansion and antibody synthesis in a similar manner in vivo. J Immunol (2000) 1.80
Chemoattraction of human blood T lymphocytes by interleukin-15. J Exp Med (1995) 1.80
Feedback inhibition of nitric oxide synthase activity by nitric oxide. Br J Pharmacol (1993) 1.79
A novel pathway regulating lipopolysaccharide-induced shock by ST2/T1 via inhibition of Toll-like receptor 4 expression. J Immunol (2001) 1.78
T-cell subsets and cytokines in parasitic infections. Immunol Today (1992) 1.77
A role for IL-18 in neutrophil activation. J Immunol (2001) 1.72
Interleukin 27 attenuates collagen-induced arthritis. Ann Rheum Dis (2008) 1.70
The initial suppression of bacterial growth in a salmonella infection is mediated by a localized rather than a systemic response. Microb Pathog (1987) 1.60
Differential induction of nitric oxide synthase in various organs of the mouse during endotoxaemia: role of TNF-alpha and IL-1-beta. Immunology (1994) 1.55
A nitric oxide synthase inhibitor reduces inflammation, down-regulates inflammatory cytokines and enhances interleukin-10 production in carrageenin-induced oedema in mice. Immunology (1994) 1.54
Delayed-type hypersensitivity to influenza virus. Induction of antigen-specific suppressor T cells for delayed-type hypersensitivity to hemagglutinin during influenza virus infection in mice. J Exp Med (1980) 1.54
Interleukin 15: a proinflammatory role in rheumatoid arthritis synovitis. Immunol Today (1998) 1.53
Interleukin 18: a pleiotropic participant in chronic inflammation. Immunol Today (2000) 1.51
Reduced incidence and severity of collagen-induced arthritis in mice lacking IL-18. J Immunol (2001) 1.50
Genetically determined susceptibility to Leishmania tropica infection is expressed by haematopoietic donor cells in mouse radiation chimaeras. Nature (1980) 1.47
Regulation of the expression of nitric oxide synthase and leishmanicidal activity by glycoconjugates of Leishmania lipophosphoglycan in murine macrophages. Proc Natl Acad Sci U S A (1996) 1.46
Protection against leishmaniasis by injection of DNA encoding a major surface glycoprotein, gp63, of L. major. Immunology (1995) 1.46
Combined effects of IL-12 and IL-18 on the induction of collagen-induced arthritis. J Immunol (2000) 1.45
Impaired liver regeneration in inducible nitric oxide synthasedeficient mice. Proc Natl Acad Sci U S A (1998) 1.44
Prophylactic immunization against experimental leishmaniasis. IV. Subcutaneous immunization prevents the induction of protective immunity against fatal Leishmania major infection. J Immunol (1985) 1.42
Nitric oxide regulates Th1 cell development through the inhibition of IL-12 synthesis by macrophages. Eur J Immunol (1998) 1.42
Identification and characterization of T helper epitopes in the nucleoprotein of influenza A virus. J Immunol (1989) 1.40
Prophylactic immunization against experimental leishmaniasis. II. Further characterization of the protective immunity against fatal Leishmania tropica infection induced by irradiated promastigotes. J Immunol (1984) 1.39
Protection in simian immunodeficiency virus-vaccinated monkeys correlates with anti-HLA class I antibody response. J Exp Med (1992) 1.38
Role of nitric oxide in the regulation of T cell functions. Ann Rheum Dis (2006) 1.38
Macrophages exposed continuously to lipopolysaccharide and other agonists that act via toll-like receptors exhibit a sustained and additive activation state. BMC Immunol (2001) 1.37
The role of interleukin 12 and nitric oxide in the development of spontaneous autoimmune disease in MRL/MP-lpr/lpr mice. J Exp Med (1996) 1.37
Priming of influenza virus-specific cytotoxic T lymphocytes vivo by short synthetic peptides. J Immunol (1991) 1.36
Monoclonal antibodies to the murine Ly-2.1 cell surface antigen. Immunology (1982) 1.35
Activated macrophages direct apoptosis and suppress mitosis of mesangial cells. J Immunol (2000) 1.34
Altered immune responses and susceptibility to Leishmania major and Staphylococcus aureus infection in IL-18-deficient mice. J Immunol (1999) 1.32
Expression of human IL-1 beta in Salmonella typhimurium. A model system for the delivery of recombinant therapeutic proteins in vivo. J Immunol (1992) 1.31
Modulation of macrophage cytokine production by ES-62, a secreted product of the filarial nematode Acanthocheilonema viteae. J Immunol (2001) 1.31
Retracted Recombinant migration inhibitory factor induces nitric oxide synthase in murine macrophages. J Immunol (1993) 1.31
Lack of a correlation between cell-mediated immunity to the carrier and the carrier-hapten helper effect. J Exp Med (1974) 1.30
Prophylactic immunization against experimental leishmaniasis. V. Mechanism of the anti-protective blocking effect induced by subcutaneous immunization against Leishmania major infection. J Immunol (1985) 1.29
Glycoinositolphospholipids of Leishmania major inhibit nitric oxide synthesis and reduce leishmanicidal activity in murine macrophages. Eur J Immunol (1995) 1.27
CD4+ but not CD8+ T cells are required for the induction of oral tolerance. Int Immunol (1995) 1.26
Induction and characterization of delayed-type hypersensitivity to influenza virus in mice. Eur J Immunol (1979) 1.26
Regulation of the immune response by antibody. I. Suppression of antibody formation and concomitant enhancement of cell-mediated immunity by passive antibody. Cell Immunol (1972) 1.25
Vaccine efficacy of Salmonella strains expressing glycoprotein 63 with different promoters. Infect Immun (1997) 1.23
Effects of nitric oxide on the induction and differentiation of Th1 cells. Eur J Immunol (1999) 1.23
Distinctive cellular immunity in genetically susceptible BALB/c mice recovered from Leishmania major infection or after subcutaneous immunization with killed parasites. J Immunol (1987) 1.22
Anti-viral immunity induced by recombinant nucleoprotein of influenza A virus. III. Delivery of recombinant nucleoprotein to the immune system using attenuated Salmonella typhimurium as a live carrier. Immunology (1990) 1.20
Mechanisms of innate resistance to Toxoplasma gondii infection. Philos Trans R Soc Lond B Biol Sci (1997) 1.20
Selective blockade of IL-15 by soluble IL-15 receptor alpha-chain enhances cardiac allograft survival. J Immunol (2000) 1.19
Mice defective in Fas are highly susceptible to Leishmania major infection despite elevated IL-12 synthesis, strong Th1 responses, and enhanced nitric oxide production. J Immunol (1998) 1.18
Induction of delayed-type hypersensitivity to Mycobacterium leprae in healthy individuals. Clin Exp Immunol (1981) 1.18
IL-18 induces the differentiation of Th1 or Th2 cells depending upon cytokine milieu and genetic background. Eur J Immunol (2000) 1.18
Enhancement of macrophage IL-1 production by Leishmania major infection in vitro and its inhibition by IFN-gamma. J Immunol (1989) 1.16
Mice lacking inducible nitric-oxide synthase are more susceptible to herpes simplex virus infection despite enhanced Th1 cell responses. J Gen Virol (1998) 1.16
Cell-cell interactions in synovitis. Interactions between T lymphocytes and synovial cells. Arthritis Res (2000) 1.15
Helper T cells induced by an immunopurified herpes simplex virus type I (HSV-I) 115 kilodalton glycoprotein (gB) protect mice against HSV-I infection. J Exp Med (1985) 1.15
Protective effect on Leishmania major infection of migration inhibitory factor, TNF-alpha, and IFN-gamma administered orally via attenuated Salmonella typhimurium. J Immunol (1998) 1.15
T helper 2 cells are subject to high dose oral tolerance and are not essential for its induction. J Immunol (1995) 1.14
Identification and characterization of host-protective T-cell epitopes of a major surface glycoprotein (gp63) from Leishmania major. Immunology (1991) 1.14
A proinflammatory role of IL-18 in the development of spontaneous autoimmune disease. J Immunol (2001) 1.14
Cell cooperation in antibody responses to influenza virus. I. priming of helper t cells by internal components of virion. Eur J Immunol (1980) 1.13
Inhibition of nitric oxide generation affects the induction of diabetes by streptozocin in mice. Biochem Biophys Res Commun (1991) 1.12
Nitric oxide mediates intestinal pathology in graft-vs.-host disease. Eur J Immunol (1992) 1.12
Regulation of macrophage IL-12 synthesis by Leishmania phosphoglycans. Eur J Immunol (1999) 1.11
Interleukin-4 transgenic mice of resistant background are susceptible to Leishmania major infection. Eur J Immunol (1993) 1.11
Dissociative effects of malarial infection on humoral and cell-mediated immunity in mice. Immunology (1979) 1.10
Antiviral immunity induced by recombinant nucleoprotein of influenza A virus. I. Characteristics and cross-reactivity of T cell responses. J Immunol (1988) 1.10
Anti-viral immunity induced by recombinant nucleoprotein of influenza A virus. II. Protection from influenza infection and mechanism of protection. Immunology (1990) 1.09
Reduction in the number of UCHL-1+ cells and IL-2 production in the peripheral blood of patients with visceral leishmaniasis. J Immunol (1991) 1.09
Interleukin-33 amplifies IgE synthesis and triggers mast cell degranulation via interleukin-4 in naïve mice. Allergy (2012) 1.08
Major histocompatibility gene complex (MHC)-coded determinants on antigen-specific suppressor factor for delayed-type hypersensitivity and surface phenotypes of cells producing the factor. Eur J Immunol (1980) 1.08
The role of inducible nitric oxide synthase in the host response to Coxsackievirus myocarditis. Proc Natl Acad Sci U S A (1998) 1.07
Activation of the inducible nitric oxide synthase pathway contributes to inflammation-induced osteoporosis by suppressing bone formation and causing osteoblast apoptosis. Arthritis Rheum (2001) 1.07
ESkine, a novel beta-chemokine, is differentially spliced to produce secretable and nuclear targeted isoforms. J Biol Chem (1999) 1.07